» Articles » PMID: 25648832

Loss of Ron Receptor Signaling Leads to Reduced Obesity, Diabetic Phenotypes and Hepatic Steatosis in Response to High-fat Diet in Mice

Overview
Date 2015 Feb 5
PMID 25648832
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The Ron receptor tyrosine kinase is a heterodimeric, membrane-spanning glycoprotein that participates in divergent processes, including proliferation, motility, and modulation of inflammatory responses. We observed male C57BL/6 mice with a global deletion of the Ron tyrosine kinase signaling domain (TK(-/-)) to be leaner compared with control (TK(+/+)) mice under a standard diet. When fed a high-fat diet (HFD), TK(-/-) mice gained 50% less weight and were more insulin sensitive and glucose tolerant than controls. Livers from HFD TK(-/-) mice were considerably less steatotic and weighed significantly less than TK(+/+) livers. Serum cytokine levels of HFD TK(-/-) mice were also significantly altered compared with TK(+/+) mice. Fewer and smaller adipocytes were present in the TK(-/-) mice on both control and HFD and were accompanied by diminished adiponectin and peroxisome proliferator-activated receptor-γ expression. In vitro adipogenesis experiments suggested reduced differentiation in TK(-/-) embryonic fibroblasts (MEFs) that was rescued by Ron reconstitution. Likewise, signal transducer and activator of transcription (STAT)-3 phosphorylation was diminished in TK(-/-) MEFs but was increased after Ron reconstitution. The adipogenic inhibitors, preadipocyte factor 1 and Sox9, were elevated in TK(-/-) MEFs and increased in both groups after STAT3 silencing. In total, these studies document a previously unknown function for the Ron receptor in mediating HFD-induced obesity and metabolic dysregulation.

Citing Articles

Transcriptome Changes and Metabolic Outcomes After Bariatric Surgery in Adults With Obesity and Type 2 Diabetes.

Rashid M, Al Qarni A, Al Mahri S, Mohammad S, Khan A, Abdullah M J Endocr Soc. 2024; 8(1):bvad159.

PMID: 38162016 PMC: 10755185. DOI: 10.1210/jendso/bvad159.


MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.

Huang L, Fang X, Shi D, Yao S, Wu W, Fang Q Front Immunol. 2020; 11:569082.

PMID: 33117355 PMC: 7577085. DOI: 10.3389/fimmu.2020.569082.


Regulation of Energy Metabolism by Receptor Tyrosine Kinase Ligands.

Zhao M, Jung Y, Jiang Z, Svensson K Front Physiol. 2020; 11:354.

PMID: 32372975 PMC: 7186430. DOI: 10.3389/fphys.2020.00354.


Receptor tyrosine kinase recepteur d'origine nantais as predictive marker for aggressive prostate cancer in African Americans.

Bedolla R, Shah D, Huang S, Reddick R, Ghosh R, Kumar A Mol Carcinog. 2019; 58(6):854-861.

PMID: 30859654 PMC: 6525017. DOI: 10.1002/mc.23002.


Transcriptomics and metabonomics analyses of maternal DEHP exposure on male offspring.

Zhang Y, Zhang W, Fu X, Zhou F, Yu H, Na X Environ Sci Pollut Res Int. 2018; 25(26):26322-26329.

PMID: 29978319 DOI: 10.1007/s11356-018-2596-8.


References
1.
Kim K, Kim J, Wang Y, Sul H . Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol Cell Biol. 2007; 27(6):2294-308. PMC: 1820487. DOI: 10.1128/MCB.02207-06. View

2.
Sadagurski M, Norquay L, Farhang J, DAquino K, Copps K, White M . Human IL6 enhances leptin action in mice. Diabetologia. 2009; 53(3):525-35. PMC: 2815798. DOI: 10.1007/s00125-009-1580-8. View

3.
Wagh P, Peace B, Waltz S . Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. Adv Cancer Res. 2008; 100:1-33. PMC: 4102433. DOI: 10.1016/S0065-230X(08)00001-8. View

4.
Wang Y, Sul H . Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab. 2009; 9(3):287-302. PMC: 2673480. DOI: 10.1016/j.cmet.2009.01.013. View

5.
Jandacek R, Heubi J, Tso P . A novel, noninvasive method for the measurement of intestinal fat absorption. Gastroenterology. 2004; 127(1):139-44. DOI: 10.1053/j.gastro.2004.04.007. View